by MyH Editorial Team | Jun 11, 2026 | Commentaries
Key Takeaways Interferon-alpha is the only PV treatment that targets the root cause. Unlike phlebotomy or hydroxyurea, recombinant interferon-alpha directly attacks the mutant stem cells driving polycythemia vera. In some patients, after 2 to 5 years of...
by MyH Editorial Team | Jun 4, 2026 | White Blood Cells
Key Takeaways CMML (chronic myelomonocytic leukemia) is a blood cancer that starts in one faulty bone marrow stem cell and causes the body to overproduce monocytes, a type of white blood cell. It sits between two disease families: myelodysplastic syndromes and...
by MyH Editorial Team | May 27, 2026 | White Blood Cells
Key Takeaways Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia driven by the t(15;17) translocation, which creates the PML-RARA fusion gene and blocks white blood cells from maturing. Symptoms ▾: Patients typically present with the...
by MyH Editorial Team | May 20, 2026 | Red Blood Cells
Key Takeaways Copper deficiency is an under-recognized cause of cytopenias and neurological disease, with the classic triad of anemia, neutropenia, and myeloneuropathy [1,3]. Causes ▾: The commonest causes are bariatric and upper gastrointestinal surgery,...
by MyH Editorial Team | May 13, 2026 | White Blood Cells
Key Takeaways Mast Cell Activation Syndrome or MCAS is a condition where a normal number of mast cells release their chemicals too easily, producing repeated symptoms across two or more organ systems. Pathophysiology and Classification ▾: MCAS involves a...
Recent Comments